Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Nov, 2014 | Pages:
693 | Publisher: Global Markets Direct
Industry: Healthcare | Report Format: Electronic (PDF)
Colorectal Cancer - Pipeline Review, H2 2014 Summary Global Markets Direct's, 'Colorectal Cancer - Pipeline Review, H2 2014', provides an overview of the Colorectal Cancer's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Colorectal Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Colorectal Cancer and special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides a snapshot of the global therapeutic landscape of Colorectal Cancer - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Colorectal Cancer and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Colorectal Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources - Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages - A detailed assessment of monotherapy and combination therapy pipeline projects - Coverage of the Colorectal Cancer pipeline on the basis of target, MoA, route of administration and molecule type - Latest news and deals relating related to pipeline products Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Colorectal Cancer - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Colorectal Cancer pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Table of Contents Table of Contents 2 Introduction 8 Colorectal Cancer Overview 9 Therapeutics Development 10 Colorectal Cancer - Therapeutics under Development by Companies 12 Colorectal Cancer - Therapeutics under Investigation by Universities/Institutes 23 Colorectal Cancer - Pipeline Products Glance 26 Colorectal Cancer - Products under Development by Companies 30 Colorectal Cancer - Products under Investigation by Universities/Institutes 43 Colorectal Cancer - Companies Involved in Therapeutics Development 45 Colorectal Cancer - Therapeutics Assessment 169 Drug Profiles 190 Colorectal Cancer - Recent Pipeline Updates 529 Colorectal Cancer - Dormant Projects 643 Colorectal Cancer - Discontinued Products 656 Colorectal Cancer - Product Development Milestones 660 Appendix 667
List of Tables Number of Products under Development for Colorectal Cancer, H2 2014 35 Number of Products under Development for Colorectal Cancer - Comparative Analysis, H2 2014 36 Number of Products under Development by Companies, H2 2014 38 Number of Products under Development by Companies, H2 2014 (Contd..1) 39 Number of Products under Development by Companies, H2 2014 (Contd..2) 40 Number of Products under Development by Companies, H2 2014 (Contd..3) 41 Number of Products under Development by Companies, H2 2014 (Contd..4) 42 Number of Products under Development by Companies, H2 2014 (Contd..5) 43 Number of Products under Development by Companies, H2 2014 (Contd..6) 44 Number of Products under Development by Companies, H2 2014 (Contd..7) 45 Number of Products under Development by Companies, H2 2014 (Contd..8) 46 Number of Products under Development by Companies, H2 2014 (Contd..9) 47 Number of Products under Investigation by Universities/Institutes, H2 2014 49 Number of Products under Investigation by Universities/Institutes, H2 2014 (Contd..1) 50 Comparative Analysis by Late Stage Development, H2 2014 51 Comparative Analysis by Clinical Stage Development, H2 2014 52 Comparative Analysis by Early Stage Development, H2 2014 53 Comparative Analysis by Unknown Stage Development, H2 2014 54 Products under Development by Companies, H2 2014 55 Products under Development by Companies, H2 2014 (Contd..1) 56 Products under Development by Companies, H2 2014 (Contd..2) 57 Products under Development by Companies, H2 2014 (Contd..3) 58 Products under Development by Companies, H2 2014 (Contd..4) 59 Products under Development by Companies, H2 2014 (Contd..5) 60 Products under Development by Companies, H2 2014 (Contd..6) 61 Products under Development by Companies, H2 2014 (Contd..7) 62 Products under Development by Companies, H2 2014 (Contd..8) 63 Products under Development by Companies, H2 2014 (Contd..9) 64 Products under Development by Companies, H2 2014 (Contd..10) 65 Products under Development by Companies, H2 2014 (Contd..11) 66 Products under Development by Companies, H2 2014 (Contd..12) 67 Products under Investigation by Universities/Institutes, H2 2014 68 Products under Investigation by Universities/Institutes, H2 2014 (Contd..1) 69 Colorectal Cancer - Pipeline by 2cureX ApS, H2 2014 70 Colorectal Cancer - Pipeline by 3-V Biosciences, Inc., H2 2014 71 Colorectal Cancer - Pipeline by 4SC AG, H2 2014 72 Colorectal Cancer - Pipeline by Adamed Sp. z o.o., H2 2014 73 Colorectal Cancer - Pipeline by Advaxis, Inc., H2 2014 74 Colorectal Cancer - Pipeline by Advenchen Laboratories, LLC, H2 2014 75 Colorectal Cancer - Pipeline by Aeterna Zentaris Inc., H2 2014 76 Colorectal Cancer - Pipeline by Agonox, H2 2014 77 Colorectal Cancer - Pipeline by AlphaMab Co., Ltd, H2 2014 78 Colorectal Cancer - Pipeline by Amgen Inc., H2 2014 79 Colorectal Cancer - Pipeline by Antibe Therapeutics, Inc., H2 2014 80 Colorectal Cancer - Pipeline by Aphios Corporation, H2 2014 81 Colorectal Cancer - Pipeline by Arisaph Pharmaceuticals, Inc., H2 2014 82 Colorectal Cancer - Pipeline by Astellas Pharma Inc., H2 2014 83 Colorectal Cancer - Pipeline by AstraZeneca PLC, H2 2014 84 Colorectal Cancer - Pipeline by Avipep Pty Ltd, H2 2014 85 Colorectal Cancer - Pipeline by Basilea Pharmaceutica AG, H2 2014 86 Colorectal Cancer - Pipeline by Bavarian Nordic A/S, H2 2014 87 Colorectal Cancer - Pipeline by Bayer AG, H2 2014 88 Colorectal Cancer - Pipeline by Bionomics Limited, H2 2014 89 Colorectal Cancer - Pipeline by Boston Biomedical, Inc., H2 2014 90 Colorectal Cancer - Pipeline by Bristol-Myers Squibb Company, H2 2014 91 Colorectal Cancer - Pipeline by CCRP Therapeutics GmbH, H2 2014 92 Colorectal Cancer - Pipeline by Celator Pharmaceuticals, Inc., H2 2014 93 Colorectal Cancer - Pipeline by Celldex Therapeutics, Inc., H2 2014 94 Colorectal Cancer - Pipeline by Cellectis S.A., H2 2014 95 Colorectal Cancer - Pipeline by Celsion Corporation, H2 2014 96 Colorectal Cancer - Pipeline by Chipscreen Biosciences Ltd, H2 2014 97 Colorectal Cancer - Pipeline by Chugai Pharmaceutical Co., Ltd., H2 2014 98 Colorectal Cancer - Pipeline by CIMAB S.A., H2 2014 99 Colorectal Cancer - Pipeline by Compugen Ltd., H2 2014 100 Colorectal Cancer - Pipeline by Critical Outcome Technologies Inc., H2 2014 101 Colorectal Cancer - Pipeline by CrystalGenomics, Inc., H2 2014 102 Colorectal Cancer - Pipeline by CTI BioPharma Corp., H2 2014 103 Colorectal Cancer - Pipeline by Deciphera Pharmaceuticals, LLC, H2 2014 104 Colorectal Cancer - Pipeline by Dendreon Corporation, H2 2014 105 Colorectal Cancer - Pipeline by Digna Biotech, S.L., H2 2014 106 Colorectal Cancer - Pipeline by Eddingpharm, H2 2014 107 Colorectal Cancer - Pipeline by Eisai Co., Ltd., H2 2014 108 Colorectal Cancer - Pipeline by Eli Lilly and Company, H2 2014 109 Colorectal Cancer - Pipeline by Enzo Biochem, Inc., H2 2014 110 Colorectal Cancer - Pipeline by Erytech Pharma SA, H2 2014 111 Colorectal Cancer - Pipeline by F-star Alpha Ltd., H2 2014 112 Colorectal Cancer - Pipeline by F. Hoffmann-La Roche Ltd., H2 2014 113 Colorectal Cancer - Pipeline by Fusion Antibodies Ltd, H2 2014 114 Colorectal Cancer - Pipeline by Genentech, Inc., H2 2014 115 Colorectal Cancer - Pipeline by Gilead Sciences, Inc., H2 2014 116 Colorectal Cancer - Pipeline by GlaxoSmithKline plc, H2 2014 117 Colorectal Cancer - Pipeline by Glycotope GmbH, H2 2014 118 Colorectal Cancer - Pipeline by Gradalis Inc., H2 2014 119 Colorectal Cancer - Pipeline by Hanmi Pharmaceuticals, Co. Ltd., H2 2014 120 Colorectal Cancer - Pipeline by Helix BioPharma Corp., H2 2014 121 Colorectal Cancer - Pipeline by Hemispherx Biopharma, Inc., H2 2014 122 Colorectal Cancer - Pipeline by Igenica Biotherapeutics, Inc., H2 2014 123 Colorectal Cancer - Pipeline by ImmunNovative Developments SL, H2 2014 124 Colorectal Cancer - Pipeline by Immunomedics, Inc., H2 2014 125 Colorectal Cancer - Pipeline by Immunovative Therapies, Ltd., H2 2014 126 Colorectal Cancer - Pipeline by IMPACT Therapeutics, Inc., H2 2014 127 Colorectal Cancer - Pipeline by Incuron, LLC, H2 2014 128 Colorectal Cancer - Pipeline by Interprotein Corporation, H2 2014 129 Colorectal Cancer - Pipeline by Intezyne, Inc, H2 2014 130 Colorectal Cancer - Pipeline by Isis Pharmaceuticals, Inc., H2 2014 131 Colorectal Cancer - Pipeline by Isofol Medical AB, H2 2014 132 Colorectal Cancer - Pipeline by ISU ABXIS Co.,Ltd., H2 2014 133 Colorectal Cancer - Pipeline by iTeos Therapeutics SA, H2 2014 134 Colorectal Cancer - Pipeline by Jiangsu Hengrui Medicine Co., Ltd., H2 2014 135 Colorectal Cancer - Pipeline by Kadmon Corporation, LLC, H2 2014 136 Colorectal Cancer - Pipeline by KAEL-GemVax Co., Ltd., H2 2014 137 Colorectal Cancer - Pipeline by Kancera AB, H2 2014 138 Colorectal Cancer - Pipeline by Laboratorio Elea S.A.C.I.F. and A, H2 2014 139 Colorectal Cancer - Pipeline by Lead Discovery Center GmbH, H2 2014 140 Colorectal Cancer - Pipeline by Lee's Pharmaceutical Holdings Limited, H2 2014 141 Colorectal Cancer - Pipeline by LG Life Sciences, Ltd., H2 2014 142 Colorectal Cancer - Pipeline by Lipopharma Therapeutics SL, H2 2014 143 Colorectal Cancer - Pipeline by LivTech, Inc., H2 2014 144 Colorectal Cancer - Pipeline by MEI Pharma, Inc., H2 2014 145 Colorectal Cancer - Pipeline by Merck & Co., Inc., H2 2014 146 Colorectal Cancer - Pipeline by Merck KGaA, H2 2014 147 Colorectal Cancer - Pipeline by Merrimack Pharmaceuticals, Inc., H2 2014 148 Colorectal Cancer - Pipeline by MolMed S.p.A., H2 2014 149 Colorectal Cancer - Pipeline by Morphotek, Inc., H2 2014 150 Colorectal Cancer - Pipeline by Multimmune GmbH, H2 2014 151 Colorectal Cancer - Pipeline by Natco Pharma Limited, H2 2014 152 Colorectal Cancer - Pipeline by NatureWise Biotech & Medicals Corporation, H2 2014 153 Colorectal Cancer - Pipeline by Nerviano Medical Sciences, H2 2014 154 Colorectal Cancer - Pipeline by Northwest Biotherapeutics, Inc., H2 2014 155 Colorectal Cancer - Pipeline by Novartis AG, H2 2014 156 Colorectal Cancer - Pipeline by NuCana BioMed Limited, H2 2014 157 Colorectal Cancer - Pipeline by Oncobiologics, Inc., H2 2014 158 Colorectal Cancer - Pipeline by Oncology Research International Limited, H2 2014 159 Colorectal Cancer - Pipeline by Oncothyreon Inc., H2 2014 160 Colorectal Cancer - Pipeline by Otsuka Holdings Co., Ltd., H2 2014 161 Colorectal Cancer - Pipeline by Oxford BioMedica plc, H2 2014 162 Colorectal Cancer - Pipeline by Panacea Biotec Limited, H2 2014 163 Colorectal Cancer - Pipeline by Pfizer Inc., H2 2014 164 Colorectal Cancer - Pipeline by Philogen S.p.A., H2 2014 165 Colorectal Cancer - Pipeline by PLx Pharma Inc., H2 2014 166 Colorectal Cancer - Pipeline by Precision Biologics, Inc., H2 2014 167 Colorectal Cancer - Pipeline by Quintessence Biosciences, Inc., H2 2014 168 Colorectal Cancer - Pipeline by Recepta Biopharma S.A., H2 2014 169 Colorectal Cancer - Pipeline by Regulon Inc., H2 2014 170 Colorectal Cancer - Pipeline by Rexahn Pharmaceuticals, Inc., H2 2014 171 Colorectal Cancer - Pipeline by Sanofi, H2 2014 172 Colorectal Cancer - Pipeline by Selvita SA, H2 2014 173 Colorectal Cancer - Pipeline by SentoClone International AB, H2 2014 174 Colorectal Cancer - Pipeline by Serina Therapeutics, Inc., H2 2014 175 Colorectal Cancer - Pipeline by Shanghai Henlius Biotech Co., Ltd., H2 2014 176 Colorectal Cancer - Pipeline by Sigmoid Pharma Limited, H2 2014 177 Colorectal Cancer - Pipeline by SillaJen Co. Ltd., H2 2014 178 Colorectal Cancer - Pipeline by Solvotrin Therapeutics Ltd, H2 2014 179 Colorectal Cancer - Pipeline by Sumitomo Dainippon Pharma Co., Ltd., H2 2014 180 Colorectal Cancer - Pipeline by Supratek Pharma Inc., H2 2014 181 Colorectal Cancer - Pipeline by Tactic Pharma, LLC, H2 2014 182 Colorectal Cancer - Pipeline by Taiho Pharmaceutical Co., Ltd., H2 2014 183 Colorectal Cancer - Pipeline by Targovax AS, H2 2014 184 Colorectal Cancer - Pipeline by Teva Pharmaceutical Industries Limited, H2 2014 185 Colorectal Cancer - Pipeline by TheRyte Ltd., H2 2014 186 Colorectal Cancer - Pipeline by Vaxeal Holding SA, H2 2014 187 Colorectal Cancer - Pipeline by Viralytics Ltd., H2 2014 188 Colorectal Cancer - Pipeline by Wellstat Biologics Corporation, H2 2014 189 Colorectal Cancer - Pipeline by WntResearch AB, H2 2014 190 Colorectal Cancer - Pipeline by XBiotech USA, Inc., H2 2014 191 Colorectal Cancer - Pipeline by Zymeworks Inc., H2 2014 192 Colorectal Cancer - Pipeline by Zyngenia, Inc., H2 2014 193 Assessment by Monotherapy Products, H2 2014 194 Assessment by Combination Products, H2 2014 195 Number of Products by Stage and Target, H2 2014 197 Number of Products by Stage and Mechanism of Action, H2 2014 205 Number of Products by Stage and Route of Administration, H2 2014 212 Number of Products by Stage and Molecule Type, H2 2014 214 Colorectal Cancer Therapeutics - Recent Pipeline Updates, H2 2014 554 Colorectal Cancer - Dormant Projects, H2 2014 668 Colorectal Cancer - Dormant Projects (Contd..1), H2 2014 669 Colorectal Cancer - Dormant Projects (Contd..2), H2 2014 670 Colorectal Cancer - Dormant Projects (Contd..3), H2 2014 671 Colorectal Cancer - Dormant Projects (Contd..4), H2 2014 672 Colorectal Cancer - Dormant Projects (Contd..5), H2 2014 673 Colorectal Cancer - Dormant Projects (Contd..6), H2 2014 674 Colorectal Cancer - Dormant Projects (Contd..7), H2 2014 675 Colorectal Cancer - Dormant Projects (Contd..8), H2 2014 676 Colorectal Cancer - Dormant Projects (Contd..9), H2 2014 677 Colorectal Cancer - Dormant Projects (Contd..10), H2 2014 678 Colorectal Cancer - Dormant Projects (Contd..11), H2 2014 679 Colorectal Cancer - Dormant Projects (Contd..12), H2 2014 680 Colorectal Cancer - Discontinued Products, H2 2014 681 Colorectal Cancer - Discontinued Products (Contd..1), H2 2014 682 Colorectal Cancer - Discontinued Products (Contd..2), H2 2014 683 Colorectal Cancer - Discontinued Products (Contd..3), H2 2014 684
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
